In line with our results in NSCLC patient samples, these studies have shown that HOTTIP upregulation is associated with increased levels of HOXA13. In contrast, however, an in vitro study in the A549 NSCLC cell line showed that silencing HOTTIP led to increased HOXA13 levels [21]. Here, HOXA13 is linked to non-small cell lung carcinoma.